fda status of bpc 157 2023 2024 The peptide gray market is about to go mainstream. According to @nytimes, the is expected to lift restrictions on certain peptides — opening the door for compounding pharmacies to sell a BPC-157: The Real Reason Why
Description
Novo Nordisk Press Release: Subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025
& Kissow, H
10.1038/emm.2016.49 310 YeM.ChungH.-S.LeeC.YoonM
Results: The neural network achieved an AUC of 0.74 using manual ground truths
